Showing results 1 to 6 of 6
| Title | Author(s) | Issue Date | |
|---|---|---|---|
| 1-Dec-2022 | |||
DAP10 integration in CAR-T cells enhances the killing of heterogeneous tumors by harnessing endogenous NKG2D Journal:Molecular Therapy - Oncolytics | 15-Sep-2022 | ||
DNMT1 inhibition reprograms T cells to NK-like cells with potent antitumor activity Journal:Science Immunology | 21-Mar-2025 | ||
Human induced-T-to-natural killer cells have potent anti-tumour activities Journal:Biomarker Research | Jiang, ZhiwuQin, LeTang, YuouLiao, RuiShi, JingxuanHe, BingjiaLi, ShanglinZheng, DiweiCui, YuanbinWu, QitingLong, YouguoYao, YaoWei, ZhihuiHong, QilanWu, YiMai, YuanbangGou, ShixueLi, XiaopingWeinkove, RobertNorton, SamLuo, WeiFeng, WeinengZhou, HongshengLiu, QifaChen, JiekaiLai, LiangxueChen, XinwenPei, DuanqingGraf, ThomasLiu, XingguoLi, YangqiuLiu, PentaoZhang, ZhenfengLi, Peng | 24-Mar-2022 | |
The Chemokine Receptor CCR8 Is a Target of Chimeric Antigen T Cells for Treating T Cell Malignancies Journal:Frontiers in Immunology | 26-May-2022 | ||
| 7-Jun-2022 |
